Hendon Partners

Industry: Hospice

Hospice M&A Advisory.

Hospice agencies command some of the highest EBITDA multiples in healthcare M&A. Hendon Partners has deep relationships with the most active acquirers in the hospice space and a proven track record of maximizing value for sellers.

Contact Us

Market Overview

The Hospice M&A Landscape

6–12×
Typical EBITDA Multiple Range
Very High
Buyer Demand & Competition
Premium
Valuations in Select Markets

Hospice agencies are among the most valuable assets in all of healthcare M&A. The predictable, Medicare-reimbursed revenue model, combined with high barriers to entry in certificate-of-need states, makes hospice businesses highly desirable to a wide range of buyers.

Key valuation drivers include average daily census (ADC), length of stay, length of service, geographic footprint, and quality metrics. Hendon helps sellers articulate and document these metrics in the most compelling way possible for buyers.

Why Hendon

What we bring to your hospice sale.

CON State Expertise

We understand the unique dynamics of Certificate of Need states and how CON licenses affect hospice valuations, often significantly increasing transaction prices.

ADC & Quality Metrics

Average daily census, length of stay, and CAHPS scores all drive hospice valuations. We help you document and present these metrics to command premium pricing.

Accreditation & Compliance

ACHC and JCAHO accreditation status matters to buyers. We help you understand how your compliance posture affects your value and transaction structure.

Premium Buyer Access

We have active relationships with the largest public and private hospice acquirers in the country, ensuring your sale process generates real competitive tension.

Frequently Asked Questions

What multiple does a hospice agency sell for in 2026?
+
Hospice agencies command the highest multiples in care-at-home M&A — generally 6–12× EBITDA. Agencies with high average daily census (ADC), favorable length of stay, clean PEPPER reports, and strong physician referral networks reach the top of that range.
What drives hospice agency valuation?
+
The biggest value drivers are average daily census (ADC), average length of stay, payer and diagnosis mix, Certificate of Need (CON) status, CAHPS scores, GIP and inpatient capabilities, and referral relationships. Documenting these in the CIM directly affects price.
Do I need a Certificate of Need (CON) to sell my hospice?
+
In CON states, the hospice license itself carries scarcity value and can materially increase your sale price. We help sellers in both CON and non-CON states position licensure as a strategic asset for acquirers.
Who is buying hospice agencies right now?
+
Active buyers include PE-backed hospice platforms, large strategic and national providers, and health systems building palliative and end-of-life programs. We run a competitive process across all three buyer types to maximize tension and price.

Go Deeper

Hospice M&A Insights

Deeper reading on hospice valuation, CON dynamics, and the 2026 deal market.

Valuation Insights

Hospice Agency Valuation in 2026: What Your Business Is Really Worth

Industry Verticals

Palliative Care Agency Valuation & M&A in 2026: Distinguished from Hospice, Different Multiples

Regulatory

Certificate of Need (CON) States Home Health M&A Guide

Seller Guides

CMS Change of Ownership (CHOW) for Home Health & Hospice: A Seller's Guide

Market Intelligence

Home Health and Hospice M&A Activity Report: Q1 2026

Market Reports

Home Care Business EBITDA Multiples: 2026 Benchmark Report

What is your hospice worth in today's market?

Get your free, confidential business valuation and understand your full range of options before speaking with any buyer.

Contact Us